Neuroimmunopathology in a murine model of neuropsychiatric lupus

被引:37
作者
Ballok, David A. [1 ]
机构
[1] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada
关键词
MRL mice; autoimmunity; neuroinflammation; neurodegeneration; impaired neurogenesis; dopamine; corticosteroids; behavioral dysfunction;
D O I
10.1016/j.brainresrev.2006.12.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Animal models are extremely useful tools in defining pathogenesis and treatment of human disease. For many years researchers believed that structural damage to the brain of neuropsychiatric (NP) patients lead to abnormal mental function, but this possibility was not extensively explored until recently. Imaging studies of NP-systemic lupus erythematosus (SLE) support the notion that brain cell death accounts for the emergence of neurologic and psychiatric symptoms, and evidence suggests that it is an autoimmunity-induced brain disorder characterized by profound metabolic alterations and progressive neuronal loss. While there are a number of murine models of SLE, this article reviews recent literature on the immunological connections to neurodegeneration and behavioral dysfunction in the Fas-deficient MRL model of NP-SLE. Probable links between spontaneous peripheral immune activation, the subsequent central autoimmune/inflammatory responses in MRL/MpJ-Tnfrsf6(lpr) (MRL-lpr) mice and the sequential mode of events leading to Fas-independent neurodegenerative autoimmune-induced encephalitis will be reviewed. The role of hormones, alternative mechanisms of cell death, the impact of central dopaminergic degeneration on behavior, and germinal layer lesions on developmental/regenerative capacity of MRL-lpr brains will also be explored. This model can provide direction for future therapeutic interventions in patients with this complex neuroimmunological syndrome. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 79
页数:13
相关论文
共 174 条
[71]  
ISENBERG D, 1989, J RHEUMATOL, V16, P1395
[72]   Prolactin in human systemic lupus erythematosus [J].
Jara, LJ ;
Vera-Lastra, O ;
Miranda, JM ;
Alcala, M ;
Alvarez-Nemegyei, J .
LUPUS, 2001, 10 (10) :748-756
[73]   The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation [J].
Jennekens, FGI ;
Kater, L .
RHEUMATOLOGY, 2002, 41 (06) :619-630
[74]   DIFFUSE CNS INVOLVEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS - INTRATHECAL SYNTHESIS OF THE 4TH COMPONENT OF COMPLEMENT [J].
JONGEN, PJH ;
BOERBOOMS, AMT ;
LAMERS, KJB ;
RAES, BCM ;
VIERWINDEN, G .
NEUROLOGY, 1990, 40 (10) :1593-1596
[75]   THE DIVERSITY OF NEUROLOGIC EVENTS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PROSPECTIVE CLINICAL AND COMPUTED TOMOGRAPHIC CLASSIFICATION OF 82 EVENTS IN 71 PATIENTS [J].
KAELL, AT ;
SHETTY, M ;
LEE, BCP ;
LOCKSHIN, MD .
ARCHIVES OF NEUROLOGY, 1986, 43 (03) :273-276
[76]  
KELLY MC, 1987, J RHEUMATOL, V14, P740
[77]   Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms [J].
Komatsu, N ;
Kodama, K ;
Yamanouchi, N ;
Okada, S ;
Noda, S ;
Nawata, Y ;
Takabayashi, K ;
Iwamoto, I ;
Saito, Y ;
Uchida, Y ;
Ito, H ;
Yoshikawa, K ;
Sato, T .
EUROPEAN NEUROLOGY, 1999, 42 (01) :41-48
[78]   Comparison of neuronal density and subfield sizes in the hippocampus of CD95L-deficient (gld), CD95-deficient (lpr) and nondeficient mice [J].
Kovac, AD ;
Grammig, J ;
Mahlo, J ;
Steiner, B ;
Roth, K ;
Nitsch, R ;
Bechmann, I .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2002, 16 (01) :159-163
[79]   Cognition and immunity: Antibody impairs memory [J].
Kowal, C ;
DeGiorgio, LA ;
Nakaoka, T ;
Hetherington, H ;
Huerta, PT ;
Diamond, B ;
Volpe, BT .
IMMUNITY, 2004, 21 (02) :179-188
[80]   New insights into the pathogenesis of systemic lupus erythematosus. [J].
Kyttaris V.C. ;
Katsiari C.G. ;
Juang Y.T. ;
Tsokos G.C. .
Current Rheumatology Reports, 2005, 7 (6) :469-475